01
Measurable reduction in HbA1c and fasting blood glucose
02
Improved insulin sensitivity, reflected in HOMA-IR
03
Normalisation of liver enzymes and reduction in hepatic fat
04
Reduction in visceral fat, the primary metabolic risk driver
05
Reduced systemic inflammation
06
Improvement in blood biological age markers
07
A structured, medically supervised pathway toward reduced medication dependency (where clinically appropriate)
08
A sustainable protocol, a permanent biological reset, not a temporary intervention